Bioactive Compounds from Momordica charantia, Nigella sativa, and Anethum graveolens against Metabolic Syndrome: Untangling the Complex Relationship

ABSTRACT

Background: Momordica charantia (MC), Nigella sativa (NS), and Anethum graveolens (AG) are widely utilized vegetables and as an herbal medicines, despite widespread use, there is no evidence of molecular mechanisms of compound-protein-pathway interaction for the treatment of metabolic syndrome (MetS). Materials and Methods:Reported phytochemicals were collated from the botanical databases and SwissTargetPrediction was utilized to predict likely protein targets. Both the STRING and KEGG databases were used to infer the protein target pathway analysis. Cytoscape v3.6.1 was employed to build the compound-protein-pathway network. AutoDock vina executed through POAP pipeline was employed for therapeutic target and compounds docking study. Molecular dynamics was performed by GROMACS. Results:34, 19, 34 phytocompounds from three plants MC, NS, and AG were predicted to target 30, 30, 28 protein targets and these targets modulated 20, 18, 22 molecular pathways respectively involved in metabolic syndrome. Neuroactive ligand-receptor interaction, Calcium, cGMP-PKG, cAMP, AMPK, PI3K-Akt, PPAR, Metabolic signaling pathways, etc were modulated by compounds. PPARG was hub gene within the network. Nigellidine from NS, Nigellimine-N-Oxide from NS, Cryptoxanthin from MC scored lowest BE with PPARG (-7.5kcal/mol), FABP1 (-8.8kcal/mol), and HMGCR (-7.1kcal/mol) protein targets respectively. MD simulation for 100ns revealed stable interactions of phytocompounds comparable to standard molecules. Conclusion: The current study identified multi-compounds containing enhanced fraction of MC, NS, and AG could be the effective therapy regimen for diabetes, obesity, and MetS.

KEYWORDS

• Anethum graveolens
• Metabolic syndrome
• Momordica charantia
• Molecular dynamcis
• Network Pharmacology
• Nigella sativa

Showing references and in-text citations exactly as published.

• DOI10.5530/jyp.2023.15.91Copy

RELATED ARTICLES

Matched on section and article type within this issue of JYP.

• Article · VOLUME 15, ISSUE 4Mechanistic Insights into Ipriflavone's Role in Postmenopausal Osteoporosis through Integrated Computational and in vitro TechniquesAnish John, Harsha Ashtekar, Dheeraj Gupta, Pankaj Kumar, Anoop Narayanan V · pp. 629–637Original ArtcileSame type: Article
• Article · VOLUME 15, ISSUE 4Synthetic Identification of New Compounds with Anti-fungal Properties of “1-[3-(2-Hydroxyphenyl)-3-Oxop ropanoyl]- 5,5-Diphenylimidazolidine -2,4-Dione and its Derivatives”Rohit Jaysing Bhor, Shabnam Babu Shaikh, Shirole Rahul Bapusaheb, Satpute Pankaj Bhausaheb, Mahesh Hari Kolhe · pp. 638–648Original ArtcileSame type: Article
• Article · VOLUME 15, ISSUE 4Inhibitory Effects of Lawsone Methyl Ether and Lawsone and their Synergistic Interactions with Acarbose against α-Glucosidase: In silico and in vitro StudiesMuhammad Khan, Muhammad Ajmal Shah, Shabana Bibi, Pharkphoom Panichayupakaranant · pp. 649–658Original ArtcileSame type: Article
• Article · VOLUME 15, ISSUE 4Effect of Hydroalcoholic Extracts of Leaves of Vitex trifolia Linn. on Chronic Inflammation and TuberculosisAryaa A. Ankalikar, Agadi Hiremath Viswanathswamy, Pradeepkumar Ronad · pp. 671–678Original ArtcileSame type: Article